The state-of-the-art pharmacotherapeutic management of neovascular age-related macular degeneration-Reference-Cited by-同舟云学术

The state-of-the-art pharmacotherapeutic management of neovascular age-related macular degeneration

Published:2022-12-05 Issue:2 Volume:24 Page:197-206
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Servillo Andrea¹²,Zucchiatti Ilaria¹²,Sacconi Riccardo¹²,Parravano Mariacristina³,Querques Lea¹²,La Rubia Paula²,Prascina Francesco¹,Bandello Francesco¹²^ORCID,Querques Giuseppe¹²^ORCID

Affiliation:

1. Division of Head and Neck, Ophthalmology Unit, IRCSS Ospedale San Raffaele, Milan, Italy

2. School of Medicine, Vita-Salute San Raffaele University, Milan, Italy

3. Ophthalmology department, IRCCS - Fondazione Bietti, Rome, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2022.2154145

Reference71 articles.

1. Risk factors for age-related macular degeneration

2. Clinical Classification of Age-related Macular Degeneration

4. The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Risk Factors for Ocular Pain in Patients Undergoing Multiple Intravitreal Injections of Anti-Vascular Endothelial Growth Factor;Clinical Ophthalmology;2024-06

2. Potential application of traditional Chinese medicine in age-related macular degeneration—focusing on mitophagy;Frontiers in Pharmacology;2024-05-17

3. Macular Neovascularization Secondary to Subclinical Angioid Streaks in Age-Related Macular Degeneration: Treatment Response to Anti-VEGF at 2-Year Follow-up;Ophthalmology and Therapy;2024-03-07

4. Experimental and mathematical approaches for drug delivery for the treatment of wet age-related macular degeneration;Journal of Controlled Release;2023-11

5. One-year outcomes of resveratrol supplement with aflibercept versus aflibercept monotherapy in wet age-related macular degeneration;International Journal of Ophthalmology;2023-09-18